Flutamide (Eulexin)

From HemOnc.org - A Hematology Oncology Wiki
Jump to: navigation, search

General information

Class/mechanism: Antiandrogen; non-steroidal. Inhibits androgen uptake and/or inhibits nuclear binding of androgen in target tissues.[1][2]
Route: PO
Extravasation: n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is used

Patient drug information

History of changes in FDA indication

  • 1/27/1989: Initial FDA approval


  1. 1.0 1.1 Flutamide (Eulexin) package insert
  2. Flutamide (Eulexin) package insert (locally hosted backup)
  3. Flutamide (Eulexin) patient drug information (Chemocare)
  4. Flutamide (Eulexin) patient drug information (UpToDate)